All Relations between Schizophrenia and Atypical antipsychotics

Publication Sentence Publish Date Extraction Date Species
Gregory Oxenkrug, Paul Summergra. Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j Mice. Molecular neurobiology. vol 57. issue 1. 2020-11-19. PMID:31515691. schizophrenia (sz) patients, especially treated with atypical antipsychotics, are at high risk of the development of metabolic syndrome that increases morbidity and mortality and impairs compliance with treatment. 2020-11-19 2023-08-13 mouse
Mirela Tiglis, Tudor Hurmuzache, Cristina Bologa, Tiberiu Paul Neagu, Liliana Mirea, Ioana Marina Grintesc. Rhabdomyolysis-Induced Acute Renal Injury in a Schizophrenic Patient. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures). vol 6. issue 4. 2020-11-18. PMID:33200097. nowadays, schizophrenia is treated with atypical antipsychotics that can determine neuroleptic malignant syndrome or rhabdomyolysis appearance. 2020-11-18 2023-08-13 Not clear
Xue-Lin Chao, Shu-Zhen Jiang, Jian-Wen Xiong, Jin-Qiong Zhan, Bo Wei, Chun-Nuan Chen, Yuan-Jian Yan. Erratum to: Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics. Current medical science. vol 40. issue 5. 2020-11-12. PMID:33123913. erratum to: changes of serum insulin-like growth factor-2 response to negative symptom improvements in schizophrenia patients treated with atypical antipsychotics. 2020-11-12 2023-08-13 Not clear
Xue-Lin Chao, Shu-Zhen Jiang, Jian-Wen Xiong, Jin-Qiong Zhan, Bo Wei, Chun-Nuan Chen, Yuan-Jian Yan. Erratum to: Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics. Current medical science. vol 40. issue 5. 2020-11-12. PMID:33123913. the article "changes of serum insulin-like growth factor-2 response to negative symptom improvements in schizophrenia patients treated with atypical antipsychotics", written by xue-lin chao, shu-zhen jiang, jian-wen xiong, jin-qiong zhan, bo wei, chun-nuan chen, yuan-jian yang was originally published electronically on the publisher's internet portal on june 2020 without open access. 2020-11-12 2023-08-13 Not clear
Antoine C El Khoury, Dominic Pilon, Laura Morrison, Nina Shak, Amanda Llaneza, Edward Kim, Patrick Lefebvr. Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia. Journal of managed care & specialty pharmacy. vol 26. issue 2. 2020-11-05. PMID:32011960. projecting the long-term economic impact of once-monthly paliperidone palmitate versus oral atypical antipsychotics in medicaid patients with schizophrenia. 2020-11-05 2023-08-13 Not clear
Jacqueline A Pesa, Erik Muser, Leslie B Montejano, David M Smith, Oren I Meyer. Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics. Drugs - real world outcomes. vol 2. issue 4. 2020-10-01. PMID:26689953. costs and resource utilization among medicaid patients with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics. 2020-10-01 2023-08-13 Not clear
Gary Remington, George Foussias, Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, Jimmy Lee, Margaret Hah. Treating Negative Symptoms in Schizophrenia: an Update. Current treatment options in psychiatry. vol 3. 2020-10-01. PMID:27376016. strategies include use of atypical antipsychotics, ensuring the lowest possible antipsychotic dose that maintains control of positive symptoms (this can involve a shift from antipsychotic polypharmacy to monotherapy), possibly an antidepressant trial (given diagnostic uncertainty and the frequent use of these drugs in schizophrenia), and non-somatic interventions (e.g., cognitive behavioral therapy, cbt). 2020-10-01 2023-08-13 human
Xin Yu, Christoph U Correll, Yu-Tao Xiang, Yifeng Xu, Jizhong Huang, Fude Yang, Gang Wang, Tianmei Si, John M Kane, Prakash Masan. Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review. Shanghai archives of psychiatry. vol 28. issue 5. 2020-10-01. PMID:28638198. efficacy of atypical antipsychotics in the management of acute agitation and aggression in hospitalized patients with schizophrenia or bipolar disorder: results from a systematic review. 2020-10-01 2023-08-13 Not clear
Xin Yu, Christoph U Correll, Yu-Tao Xiang, Yifeng Xu, Jizhong Huang, Fude Yang, Gang Wang, Tianmei Si, John M Kane, Prakash Masan. Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review. Shanghai archives of psychiatry. vol 28. issue 5. 2020-10-01. PMID:28638198. among available approaches, we discuss in detail recent evidence supporting the use of intramuscular (im) antipsychotics and some recently approved oral atypical antipsychotics for the management of acute aggression and agitation in hospitalized patients with bipolar disorder or schizophrenia presenting with acute agitation or aggression, highlighting some differences between individual antipsychotic agents. 2020-10-01 2023-08-13 Not clear
Eiji Kirin. Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29209406. serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. 2020-10-01 2023-08-13 Not clear
Saeed Ahmed, Ali Mahmood Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, Mustafa Quresh. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis. Heliyon. vol 3. issue 11. 2020-10-01. PMID:29264404. to assess the relative efficacies of clozapine plus electroconvulsive therapy (ect) compared against non-clozapine typical and atypical antipsychotics plus ect for the treatment of "treatment resistant schizophrenia" (trs). 2020-10-01 2023-08-13 Not clear
Congjie Wang, Wenjie Shi, Chengbing Huang, Jiannan Zhu, Wenzhong Huang, Gang Che. The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29299043. the efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial. 2020-10-01 2023-08-13 Not clear
Congjie Wang, Wenjie Shi, Chengbing Huang, Jiannan Zhu, Wenzhong Huang, Gang Che. The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29299043. this study attempted to understand whether there are any differences in efficacy, acceptability, and safety between the five atypical antipsychotics in patients with first-episode schizophrenia. 2020-10-01 2023-08-13 Not clear
Kyle J Burghardt, Jacyln M Goodrich, Brittany N Lines, Vicki L Ellingro. The Influence of Metabolic Syndrome and Sex on the DNA Methylome in Schizophrenia. International journal of genomics. vol 2018. 2020-10-01. PMID:29850476. within this study, the dna methylome was profiled to identify altered methylation associated with metabolic syndrome in a schizophrenia population on atypical antipsychotics. 2020-10-01 2023-08-13 Not clear
Zhi-Min Yu, Ying Zhao, Jin-Qiong Zhan, Tao Luo, Jian-Wen Xiong, Bin Yu, Bo Wei, Yuan-Jian Yan. Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30687138. atypical antipsychotics can produce cognitive benefits in schizophrenia patients. 2020-10-01 2023-08-13 Not clear
Zhi-Min Yu, Ying Zhao, Jin-Qiong Zhan, Tao Luo, Jian-Wen Xiong, Bin Yu, Bo Wei, Yuan-Jian Yan. Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30687138. in this study, we conducted a prospective observation trial to explore whether plasma adma may serve as an indicator for evaluating cognitive improvements induced by atypical antipsychotics in patients with schizophrenia. 2020-10-01 2023-08-13 Not clear
V P Matei, T Purnichi, A Mihailescu, R Grigora. PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS. Acta endocrinologica (Bucharest, Romania : 2005). vol 14. issue 4. 2020-10-01. PMID:31149301. prolactin level in patients with first episode schizophrenia treated for one year with atypical antipsychotics. 2020-10-01 2023-08-13 Not clear
Carol Hensha. Reproductive risk: its role in maternal mental health. International psychiatry : bulletin of the Board of International Affairs of the Royal College of Psychiatrists. vol 7. issue 3. 2020-10-01. PMID:31508046. in high-income countries, the widespread use of atypical antipsychotics, most of which do not impair reproductive function, may lead to increased conception rates in women with schizophrenia. 2020-10-01 2023-08-13 Not clear
Yongmin Kim, Sheng-Min Wang, Kyung-Phil Kwak, Ho-Kyoung Yoon, Chi-Un Pae, Jung-Jin Kim, Won-Myong Bah. Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 4. 2020-09-30. PMID:27776390. despite numerous atypical antipsychotics (aap) available, many patients with schizophrenia still experience lack of efficacy and persistent side-effects. 2020-09-30 2023-08-13 Not clear
Yingchan Wang, Weijun Tang, Xiaoduo Fan, Jianye Zhang, Daoying Geng, Kaida Jiang, Dianming Zhu, Zhenhua Song, Zeping Xiao, Dengtang Li. Resting-state functional connectivity changes within the default mode network and the salience network after antipsychotic treatment in early-phase schizophrenia. Neuropsychiatric disease and treatment. vol 13. 2020-09-30. PMID:28223812. the purpose of this study was to examine the effects of atypical antipsychotics on dmn and sn and the relationship between these effects and symptom improvement in patients with schizophrenia. 2020-09-30 2023-08-13 Not clear